Navigation Links
University of Maryland, Baltimore BioPark Signs Gliknik Inc. as First Tenant in Its BioInnovation Center in Building Two
Date:1/9/2008

BALTIMORE, Jan. 9 /PRNewswire-USNewswire/ -- The University of Maryland, Baltimore (UMB) BioPark today announced that Gliknik Inc., a Baltimore-based biotech company, is the first tenant in the BioInnovation Center, located in UMB BioPark's Building Two.

Gliknik is creating novel biotechnology drugs for autoimmune diseases and cancer, the foundation of which resulted principally from the labs of Dr. Scott Strome, Professor and Chairman of the Department of Otorhinolarynogology, University of Maryland School of Medicine.

The UMB BioPark's BioInnovation Center consists of 8,500 square feet of space, including 10 wet labs, five office suites, a shared conference room, kitchenette, and equipment room, which provide bioscience companies affordable, pre-built wet lab and office space through short-term leases. Gliknik will reside in two labs of the Center upon its build-out completion, expected by March.

"We are thrilled to welcome the first BioInnovation Center tenant," said Jim Hughes, president of the UMB BioPark. "This unique space will fill a critical need in the Baltimore region and Gliknik is just the first of many innovative life sciences companies that will benefit from its flexibility and cost-effective structure."

"Gliknik is pleased to be both a licensee of UMB technology and an early resident of the BioInnovation Center at the UMB BioPark," said David S. Block, President and CEO, Gliknik Inc. "We have enjoyed working closely with UMB and Wexford Science + Technology. Gliknik looks forward to bringing novel drugs into clinical trials with the goal of helping patients with autoimmune diseases and cancer." Gliknik was represented in this transaction by Grubb & Ellis.

About Gliknik

Gliknik Inc. is a privately owned corporation committed to the discovery and development of novel biomolecules for autoimmune diseases and cancer. The company capitalizes on its expertise in immunology and tumor immunology. Gliknik's lead compounds are novel T cell vaccines in clinical safety studies. Gliknik also has created recombinant mimetics of intravenous immune globulin and recombinant mimetics of monoclonal antibodies. For further information, please visit http://www.gliknik.com.

About Wexford Science+Technology

A wholly owned subsidiary of Wexford Equities, LLC, Wexford Science+Technology is a privately held real estate investment and development company based in Baltimore, MD. With a team of real estate, finance and engineering experts, Wexford is devoted to developing innovative real estate solutions that inspire creativity and advance new technologies. For more information, please visit http://www.wexfordequities.com.

About UMB BioPark

The University of Maryland, Baltimore BioPark offers sophisticated laboratory and office space for early-stage to mature bioscience companies. To date, the UMB BioPark includes 360,000 square feet in two multi tenant buildings and one 638 space parking garage. The project has created 200 jobs and $128 million in capital investment. The BioPark was named by the Association of University Research Parks as the best emerging research park on the year in October 2007. For more information, please visit http://www.umbbiopark.com


'/>"/>
SOURCE Gliknik Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. GlaxoSmithKline Recognizes University of Michigans Dr. Daniel F. Hayes as the First Recipient of the Gianni Bonadonna Breast Cancer Award
2. BioMarin Licenses Technology From Leading Cystic Fibrosis Research Laboratory at the University of California, San Francisco
3. Microchip Biotechnologies, Inc. Secures Exclusive License to Use New University of Alberta Technology for Developing Microfluidic Devices
4. Alliance for Medical Devices, Instrumentation and Diagnostics formed between Fraunhofer Center for Manufacturing Innovation and Boston University
5. The University of Nottingham in the British Midlands Announces Development of Possible Hepatitis C Vaccine
6. University of Leicester scientists discover technique to help friendly bacteria
7. MichBio Announces Student Career Day at Michigan State University
8. Dr. Thomas Van Dyke Renowned Boston University Professor Joins Imagenetixs Medical Advisory Board
9. University HealthSystem Consortium Chooses SciQuest to Optimize Medical Research Procurement
10. Helix Biopharma announces addition of University of Arizona professor Kenneth Hatch as new medical advisor
11. McGill University Purchases GenVaults Personal Archive System to Manage Rare Cancer Samples
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... 2016 Oxford Gene Technology ... NGS panel range with the launch of the SureSeq myPanel™ ... of variants in familial hypercholesterolemia (FH). The panel delivers single ... a single small panel and allows customisation by ,mix and ... exons for LDLR , P C ...
(Date:12/8/2016)... Worcester, Mass (PRWEB) , ... December 08, 2016 ... ... KbioBox genetic data bioInformatics portal. In response to client demand KbioBox developed a ... gene edit biodesign program. Both are accessible from KBioBox’s new website, https://www.kbiobox.com/ ...
(Date:12/8/2016)... Francisco, CA (PRWEB) , ... December 08, 2016 ... ... Oculus as finalists in the World Technology Awards. uBiome is one of just ... received across all categories. , In addition to uBiome, companies nominated as finalists ...
(Date:12/8/2016)... , Dec. 8, 2016  Soligenix, Inc. (OTCQB: ... company focused on developing and commercializing products to ... medical need, announced today the long-term follow-up data ... (dusquetide), a first-in-class Innate Defense Regulator (IDR), in ... and neck cancer patients undergoing chemoradiation therapy (CRT).  ...
Breaking Biology Technology:
(Date:11/30/2016)... , Nov. 30, 2016 Not many of us realize that we ... of recovery so we need to do it well. Inadequate sleep levels have been ... blood pressure, stroke, diabetes, and even cancer. Maybe now is the best ... that could help them to manage their sleep quality? ... ...
(Date:11/29/2016)... BOSTON , Nov. 29, 2016 BioDirection, ... rapid point-of-care products for the objective detection of concussion ... the company has successfully completed a meeting with the ... company,s Tbit™ blood test Pre-Submission Package. During the meeting ... Tbit™ system as a precursor to commencement of a ...
(Date:11/29/2016)... CANNES, France , November 29, 2016 Nearly ... Continue Reading ... ... System is part of an efficient Identity Management. (PRNewsFoto/DERMALOG Identification Systems) ... DERMALOG is Germany's largest Multi-Biometric ...
Breaking Biology News(10 mins):